Morgan Stanley’s IM Cannabis IMCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-3
Closed -$139 – 8391
2025
Q4
$139 Buy
+3
New +$146 ﹤0.01% 7671
2024
Q3
– Hold
0
– -$2 – 7979
2024
Q2
– Hold
0
– – – 7830
2024
Q1
– Hold
0
– – – 7801
2023
Q4
– Hold
0
– – – 7807
2023
Q3
– Hold
0
– – – 7589
2023
Q2
– Hold
0
– – – 7626
2023
Q1
– Hold
0
– – – 7689
2022
Q4
– Hold
0
– – – 7837
2022
Q3
– Hold
0
– – – 7789
2022
Q2
– Hold
0
– – – 7884
2022
Q1
– Hold
0
– -$2K – 8032
2021
Q4
– Sell
-1
Closed -$5.85K – 7796
2021
Q3
$6K Hold
1
– – ﹤0.01% 7447
2021
Q2
$6K Buy
+1
New +$9.9K ﹤0.01% 7342
2021
Q1
– Hold
0
– – – 7349

Other funds holding IMCC

Morgan Stanley's IMCC Position: Q1 2026 in Review

Morgan Stanley sold out of IM Cannabis (IMCC) in Q1 2026, closing a stake of 3 shares — an estimated $139 sold.

Morgan Stanley first reported a position in IMCC in Q2 2021 and held it in 3 quarters. The position peaked at $6K in Q3 2021. 6 funds tracked by Wall St. Rank hold IMCC as of Q1 2026.

  • Morgan Stanley reported no remaining IM Cannabis position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 3 IM Cannabis shares in Q1 2026, an estimated $139.
  • Morgan Stanley first reported a position in IM Cannabis in Q2 2021 and held it in 3 quarters.
  • Morgan Stanley's IM Cannabis position peaked at $6K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held IM Cannabis as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.